Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biologics for Congenital Ichthyosis in Children
NCT04996485Phase 4Unknown
- Start
- Mar 2021
- Primary completion
- Mar 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, open-label trial of secukinumab, ustekinumab and dupilumab in congenital ichthyosis. Status: unknown.
02
Drugs
03
Conditions
congenital ichthyosis
Beyond the preview
Go deeper on NCT04996485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04996485.